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Background: Major depression is a world-wide problem that can be treated with various forms of psychotherapy.
There is strong research support for treating major depression using cognitive behavior therapy delivered in the
format of guided self-help via the Internet (ICBT). Recent research also suggests that psychodynamic psychotherapy
can be delivered as guided self-help via the Internet (IPDT) and that it seem to be as effective as ICBT for mild to
moderate depression. However, no head-to-head comparison between the two treatments exists. In the field of
Internet interventions it is largely unexplored if treatment preference affects outcome and adherence.
Methods: Participants were allocated to IPDT or ICBT based on their stated preference. More than half of the participants
preferred ICBT (N = 30) over IPDT (N = 14). Differences in efficacy between treatments were explored. Correlations
between strength of preference and treatment outcome, adherence to treatment and completion of the whole
treatment program were explored. Data were collected before and after treatment, as well as in a 7-month follow-up.
Results: During the treatment period, both programs performed equally well in reducing symptoms. More participants
who received IPDT completed the entire program. At follow-up, mixed-effects models showed that participants who
chose ICBT improved more in terms of quality of life. The ICBT group also had a significant increase in participants who
recovered from their depression from post-treatment to follow-up. Exploratory analyses indicated that strength of
preference was correlated with adherence to treatment and completion of the whole program, and long-term outcome
for the ICBT group.
Conclusions: Few differences were found during the acute treatment phase, but the long-term effects are in favor of
ICBT. Strength of preference for treatment seems to have a predictive value. Further research comparing the efficacy of
ICBT and IPDT, and the effects of preference matching and strength of preference, is warranted.
Trial registration: This trial is a continuation of the study registered as NCT01324050 at Clinicaltrials.gov.
Keywords: Depression, Psychodynamic therapy, Cognitive behavioral therapy, Internet-based psychotherapy,
Treatment preferencesBackground
Major depression is a common major health problem,
which significantly affect the individual and generates sub-
stantial costs for society [1,2]. Only 18-25% of patients in a
US 12-month prevalence study were adequately treated,
indicating that individuals with depression are an
undertreated group [1]. Several forms of psychological* Correspondence: robert.johansson@liu.se
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reproduction in any medium, provided the ortreatments are effective in the treatment of depression [3].
A majority of studies have examined cognitive behavior
therapy (CBT) which has gained a strong research support
[3]. Psychodynamic psychotherapy (PDT) is also effective
in the treatment of depression [4].
In the last decade, Internet-based psychological treat-
ments have been developed for a range of psychiatric con-
ditions, including depression [5,6]. Research has shown
that guided Internet treatments are effective in the treat-
ment of depression and anxiety disorders [7,8]. Close to
all of these treatments has been based on cognitivetral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Johansson et al. BMC Psychiatry 2013, 13:268 Page 2 of 9
http://www.biomedcentral.com/1471-244X/13/268behavior therapy (ICBT) [6]. However, results from a re-
cent randomized trial indicate that guided self-help via the
Internet is a promising treatment format also for psycho-
dynamic therapy (IPDT), at least when targeting depres-
sion [9], and potentially also for generalized anxiety
disorder [10]. While the study by Johansson et al. [9] indi-
cated that IPDT may be on par with ICBT in the treat-
ment of depression, to the best of our knowledge, no
head-to-head comparisons exist.
Patients’ preferences
Patients’ preferences in psychotherapy and pharmacother-
apy are generally considered to be a factor that influences
treatment outcome and probability of dropout [11,12].
Most studies have investigated the beneficial effect of be-
ing matched with one’s preferred treatment related to out-
come. More specifically, other studies have investigated
the differences in outcome between participants who did
receive a preferred treatment and those who did not.
Overall, a recent meta-analysis [12] has found this effect
size to be d = 0.31 (95% CI: 0.20 – 0.43). The analysis
found significant heterogeneity among studies, with indi-
cations that factors such as study design and type of con-
dition treated may moderate outcome. Moreover, Swift
and colleagues [12] found an indication that the effect of
being matched to a preferred treatment may be larger in
studies investigating psychotherapy vs. pharmacotherapy
than in psychotherapy vs. psychotherapy trials.
There is also a substantial number of studies investigat-
ing the effect of being matched with preferred treatment,
related to treatment dropout. In terms of odds ratios, Swift
et al. [12] found the overall effect of preference on dropout
to be OR = 0.59 (95% CI: 0.44 – 0.78), indicating that the
odds of dropping out of therapy prematurely in partici-
pants who were matched to their preference were between
a half and a third, compared to participants who were not
matched.
While many studies exist on the effect of preference
matching, there are, to our knowledge, only two studies
that investigate the influence of strength of preference on
treatment outcome and dropout [13,14]. In Raue et al. [13]
participants were asked the question “I wish to receive
counseling or psychotherapy for my depression” and
strength of preference was measured by a 5-point Likert
scale (1, strongly disagree; 5, strongly agree). Raue et al.
[13] found that adherence to treatment could be predicted
by preference strength but not from preference match in a
sample of depressed participants, receiving either 12 weeks
of interpersonal psychotherapy plus additional booster ses-
sions, or 20 weeks of escitalopram. Furthermore, strength
of preference could predict whether a patient started treat-
ment or not [13]. However, neither preference match nor
preference strength could predict symptom remission, al-
though an unexpected negative association was foundbetween preference strength and symptom severity at 12
weeks [13]. Dunlop et al. [14] also investigated the effect
of preference strength in addition to preference matching
in a study comparing CBT and escitalopram among
patients with depression. In contrast to Raue et al. [13],
Dunlop et al. [14] did not find any predictive value in
strength of preference.
Not much is known regarding the role of preferences in
ICBT and IPDT. However, in a pilot study on tailored
Internet treatment for anxiety it was found that the treat-
ment was effective when participants were allowed to
choose treatment components [15].
In summary, there is some evidence suggesting that
being matched to one’s preferred treatment can affect
outcome and dropout. However, the predictive value of
preference strength is largely unknown.
Study aims
The primary aim of this pilot study was to make a prelim-
inary investigation of differential efficacy between a psy-
chodynamic and a cognitive-behavioral Internet-delivered
psychological treatment in a sample of participants with
major depression. A further aim of the study was to test




The study was approved by the Regional Ethics Board of
Linköping, Sweden (Registration number 2010/386-31).
All participants provided signed informed consent via
the online treatment platform.
Participants
A detailed description of the initial recruitment and selec-
tion procedures can be found in Johansson et al. [9].
Briefly, participants were all at least 18 years old and had a
diagnosis of major depression, with no risk of suicidality
and not having other primary disorders that needed differ-
ent treatments or that could be affected negatively by the
treatment. The current pilot study involved those who
participated in the control group of the original trial. As
described in Johansson et al. [9], the control condition
consisted of a structured support intervention given for 10
weeks. Participants in that group improved considerably,
as evident by the within-group effect size of d = 0.84 on
the BDI-II, which was the primary outcome measure [9].
When the original trial was completed, the participants
from the control group (from this point on, these individ-
uals are referred to as “the participants”) were about to be
crossed over to treatment. Importantly, at time of the ori-
ginal post-treatment measure the participants were given
the opportunity to choose between the IPDT protocol
tested in Johansson et al. [9] or a previously developed
Johansson et al. BMC Psychiatry 2013, 13:268 Page 3 of 9
http://www.biomedcentral.com/1471-244X/13/268ICBT treatment [16]. Both treatments targeted depression,
lasted for 10 weeks and were delivered via the Internet. Of
the original 46 participants, 2 stated that they did not want
any further treatment. Of the remaining 44, there were
more participants who preferred ICBT (N = 30; 68.2%)
than those preferring IPDT (N = 14; 31.8%). A two-tailed
binomial test confirmed the difference to be significant
(p = .023). Demographic data for the 44 participants are
presented in Table 1. No significant differences were found
between the two groups at baseline on any measure or
demographic variable.
Preference statement and strength of preference
Descriptions of the two treatments, which were roughly
half a page each, were provided to the participants. This
information was similar in structure for both alternatives,
and contained the sections “How psychiatric problems are
explained”, “Way of working in therapy” and “Internet-
based psychodynamic psychotherapy/cognitive behavioral





Marital status Married or co-habiting
Other
Educational level College or university, at least 3 y




Medication status at intake Present
Prior history
No history
Psychological treatment Prior history
No history
Depression at intake In acute episode
In partial remission






Strength of preference Mean (SD)
Min – Max
Note: ICBT = Internet-based cognitive-behavioral therapy; IPDT = Internet-based psyctherapy emphasized the interpersonal nature of psychiatric
problems, the use of reflection as a mean of working with
the material and the treatment focus on how to reveal un-
conscious recurring patterns in life. The description of
CBT stated that cognitions and behavioral patterns inter-
act to maintain depression and did also explain how the
treatment would address both depressive thinking and
help the client expose himself/herself to fearful situations
systematically. Furthermore, the CBT description men-
tioned problem registration and homework as important
ingredients in the Internet-based CBT treatment. The de-
scriptions of CBT and PDT were based on material from
another research project investigating attitudes towards
different treatment alternatives (unpublished). In that pro-
ject, experts on both CBTand PDTconfirmed the descrip-
tions to be representative.
All participants needed to state whether they preferred
IPDT or ICBT. Importantly, it was clear to all participants
that they would receive the treatment they preferred. In
addition, all participants had to state the strength for theirICBT (N = 30) IPDT (N = 14)
20 (66.7%) 10 (71.4%)
10 (33.3%) 4 (28.6%)
46.0 (13.1) 44.4 (12.9)
25 – 72 21 – 65
19 (63.3%) 10 (71.4%)
11 (36.7%) 4 (28.6%)
ears 24 (80.0%) 9 (64.3%)
n 3 years 3 (10.0%) 2 (14.3%)
3 (10.0%) 3 (21.4%)
26 (86.7%) 10 (71.4%)
4 (13.3%) 4 (28.6%)
5 (16.7%) 4 (28.6%)
8 (26.7%) 4 (28.6%)
17 (56.7%) 6 (42.9%)
17 (56.7%) 7 (50.0%)
13 (43.3%) 7 (50.0%)
20 (66.7%) 8 (57.1%)
10 (33.3%) 6 (42.9%)
8 (26.7%) 5 (35.7%)
7 (23.3%) 3 (21.4%)
1 (3.3%) 1 (7.1%)
1 (3.3%) 0 (0.0%)
0 (0.0%) 0 (0.0%)
13 (43.3%) 9 (64.3%)
2.90 (0.85) 2.93 (1.07)
1 – 4 1 – 4
hodynamic therapy.
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with a single question: “How important is this choice for
you?”. Possible answers included 1 = “Not important at all
(I does not matter what treatment I receive)”, 2=“Not very
important”, 3=“Fairly important”, 4=“Very important (it is
very much important which treatment I receive)”. In ac-
cordance with Raue et al. [13], we considered preference
strength to be a continuous measure.Outcome measures
The BDI-II was used as the primary outcome measure
and was administered at pre-treatment, weekly during
treatment, at post-treatment and at a 7-month follow-up.
Secondary measures of depression were the self-rated ver-
sion of the Montgomery-Åsberg Depression Rating Scale
(MADRS-S; [17]) and the 9-item Patient Health Question-
naire Depression Scale (PHQ-9; [18]). Measures of anxiety
included the Beck Anxiety Inventory (BAI; [19]) and the
7-item Patient Health Questionnaire Generalized Anxiety
Disorder Scale (GAD-7; [20]). Moreover, the Quality of
Life Inventory (QOLI; [21]) was included as a measure of
life satisfaction. All secondary measures were collected
pre-treatment, post-treatment and at the 7-month follow-
up. The measures were administered via the Internet,
which has been shown to be a valid format for question-
naires regarding depression and anxiety [22,23]. At follow-
up, a clinical interview was also conducted which aimed at
estimating global improvement, measured by the 7-point
version of the Clinical Global Impression-Improvement
(CGI-I) scale [24]. The CGI-I ranges from −3 (“very much
worse”) to 3 (“very much improved”) where a 0 means
“neither better nor worse”.Treatments
Both treatments lasted for 10 weeks and were given as
guided self-help, with participants taking part of text-
based modules through a secure online environment.
The modules were complemented by therapist support
in a medium similar to e-mail. Procedures and character
of support were similar to that of many other guided
self-help treatments tested [5]. In both treatments, ther-
apists gave feedback on the clients’ experiences and
reported work done during the week. The therapists
also adminstered the gradual access to the modules.
While we did not log the exact therapist time per client,
we have assumed that a similar amount of support were
given in this study, as compared to the original study in
which 13.2 minutes per client and week were reported
[9]. The ICBT treatment was 150 pages of text in total,
and the IPDT contained 167 pages. Modules were
roughly equal in layout, number of illustrations and
number of case examples.Psychodynamic treatment
The IPDT treatment was based on the book “Make the
leap” [25] and contained extra material including a
psychodynamic understanding of how depression is
developed and maintained. Participating individuals
were guided through a program called SUBGAP, which
stands for (I) Seeing unconscious patterns that contrib-
ute to emotional difficulties, (II) Understanding these
patterns, (III) Breaking such unhelpful patterns, and
(IV) Guarding Against Patterns and/or relapses in the
future. Briefly, the nine treatment modules included (1)
Introduction to SUBGAP; (2) Techniques and practice
on how to discover one’s own unconscious patterns; (3)
Material on how to understand patterns from both a
historical perspective and a here-and-now perspective;
(4) Techniques on how to break unhelpful patterns; (5)
Material on how to minimize the risk of falling back
into one’s old and unproductive patterns; (6) Applica-
tion of the obtained knowledge in working life; (7) Ma-
terial on how to apply the knowledge about patterns
with a focus on personal relationships; (8) A presenta-
tion of a models which connects unconscious patterns
and depression, and (9) A summary of the treatment
and material on how to prevent relapse. A detailed de-
scription can be found in [9]. All modules ended with a
proposal on how the participants could try out various
SUBGAP strategies that had been presented. Partici-
pants were encouraged to contact their therapists once
a week to describe their experiences from working with
the material. These tasks were encouragements for re-
flections and were in general about writing about expe-
riences, rather than completing typical exercises. The
therapists provided feedback on the participants’ experi-
ences and administered the gradual access to the
modules.
Cognitive behavioral treatment
The ICBT treatment used in this study was based on the
treatment protocol tested in previous trials [16,26], but with
an extra chapter added on anxiety and worry management.
The ten treatment modules included (1) Introduction to
depression and the treatment (psychoeducation); (2–3) Be-
havioral activation; (4–5) Cognitive restructuring; (6) Anx-
iety and worry management; (7) Sleep management; (8–9)
Further practice by combining previous modules, and (10)
Relapse prevention and maintenance of progress. All mod-
ules contained homework, which typically contained vari-
ous exercises related to the content from the modules.
Examples of exercises include completing activity sheets,
working with automatic thoughts and handling sleep prob-
lems by managing sleep hygiene. Therapists worked simi-
larly in the ICBT condition, as in the IPDT condition. This
included giving feedback and administering the gradual
feedback to modules.
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Four of the original six last-semester M.Sc. clinical psych-
ologist students were also therapists in this pilot trial. All
these four therapists had clients from both treatment
groups. These therapists had a general training in psycho-
therapy, i.e. they were not specialized in neither CBT nor
PDT. However, they all had clinical training and 16 weeks
of internship. In addition, a clinical psychologist trained in
CBT and with experience of the ICBT manual, partici-
pated as a therapist in the ICBT group. As described
above, the role of the therapists were similar for the two
groups. Further clinical procedures were similar to those
described in [9].
Statistical analyses
The study had an open design in that no control group
was used. However, differences between groups formed on
preference were explored. To investigate group differ-
ences, interaction effects of group and time were modeled.
The continuous outcome variables were analyzed using
random intercept models with Maximum Likelihood esti-
mation. These models have the ability to handle missing
data and therefore the intention-to-treat principle was ad-
hered to [27]. Data from pre-treatment, post-treatment
and the follow-up were analyzed. For the BDI-II, the
weekly measures were also included in the model.
To study if strength of preference was correlated with
treatment outcome, the BDI-II scores were transformed
before the analyses. In line with the recommendations
by Steketee and Chambless [28], residual gain scores for
the BDI-II at post-treatment and at follow-up were cal-
culated, instead of using crude raw scores. This calcula-
tion transforms individual scores relative typical gains
made by other study participants having similar pre-
treatment scores. The residual gain scores were calcu-
lated using the formula [Z2 – (Z1 × r12)], where Z2 is the
standardized score for the second time point (post-treat-
ment or follow-up) and Z1 is the standardized score for
the first time point (pre-treatment), and r12 is the Pear-
son correlation between scores at the two occasions
[28]. The correlations between strength of preference
and residual gain scores (for post-treatment and follow-
up) were studied for the entire sample, as well as for the
two treatment groups separately.
Recovery after treatment was investigated at post-
treatment and at follow-up. In accordance with Johansson
et al. [9], recovery was defined as a BDI-II score of ≤ 10.
This definition is also in line with previous trials on de-
pression [29,30].
Within- and between-group effect sizes (Cohen’s d)
were calculated by dividing the differences in means by
the pooled standard deviations, as described in Borenstein
et al. [31]. The between-group effect sizes can be
interpreted as follows: an effect size in the range of 0.20–0.49 is small, while 0.50–0.79 is moderate, and an effect
size over 0.80 is large [32].
Results
Attrition and adherence
All participants had provided post-treatment data in the
original trial, which served as a pre-treatment assessment
in this study. Eleven out of 44 participants (25.0%; 23.3%
ICBT and 28.6% IPDT) did not provide post-treatment
data. At the 7-month follow-up, 4 out of 44 participants
(9.1%; 6.7% ICBT and 14.3% IPDT) did not provide self-
report data. Four participants from the ICBT group and
two from the IPDT group were unreachable for the tele-
phone interview and were in accordance with the
intention-to-treat principle classified as unimproved on
the CGI-I.
The number of completed treatment modules was used
as a measure of adherence. In the psychodynamic group, a
module was considered to be finished only if the weekly
discussion of the module was sent to the therapist. Simi-
larly, in the ICBT group, the module was classified as fin-
ished when the homework had been completed. Mean
percentage of completed modules was 62.0% (SD = 33.2%)
in the ICBT group and 73.8% (SD = 35.8%) in the IPDT
group. This difference was not significant (t(42) = 1.07,
p = .29). However, there were more participants who com-
pleted the whole program in the IPDT group (57.1%) than
in the ICBT group (26.7%), χ2(N = 44, df = 1) = 3.83, p = .05.
Primary outcome measure
Mixed-effects model analyses showed that both groups
improved on the BDI-II from pre-treatment to post-
treatment (F(1, 253.0) = 100.6, p < .001, for the ICBT group
and F(1, 117.1) = 42.0, p < .001, for the IPDT group). This
is mirrored by within-group effect sizes on the BDI-II
around d = 1.0 in both groups, as seen in Table 2. No sig-
nificant further effects of time were found within the
groups from post-treatment to follow-up. There were no
significant interaction effects of group and time, neither
from pre to post, nor pre to follow-up (both F’s < 0.37,
both p’s > .55).
Secondary outcome measures
For secondary measures of depression (the MADRS-S and
the PHQ-9), random intercept models showed significant
effects of time in both groups, from pre-treatment to post-
treatment (all F’s > 10.3, all p’s < .01). No significant inter-
action effects of group and time were observed - neither on
the MADRS-S nor the PHQ-9.
For other secondary measures (GAD-7, BAI and QOLI),
the mixed models-analyses showed significant effects of
time from pre-treatment to post-treatment in the CBT
group (all F’s > 4.51, all p’s < .05). No effects of time were
found in the IPDT group for the BAI or the QOLI (both
Table 2 Descriptive statistics of means, SDs and effect sizes (Cohen’s d) for measures of depression, anxiety and quality of life
Mean (SD) Effect size d (95% CI)







Pre tx – Post tx
Within-group,
Post tx - 7mo
BDI-II
ICBT 26.10 (6.7) 19.57 (8.0) 12.26 (6.6) 10.36 (10.6) 0.33 (−0.42 – 1.07) 0.45 (−0.23 – 1.14) 1.04 (0.61 – 1.48) 0.20 (−0.10 – 0.50)
IPDT 26.29 (6.8) 22.29 (7.4) 14.60 (8.5) 15.42 (12.6) 1.06 (0.45 – 1.67) −0.13 (−0.69 – 0.43)
MADRS-S
ICBT 24.17 (4.6) 18.30 (6.8) 12.78 (7.8) 11.11 (8.2) 0.28 (−0.46 – 1.03) 0.32 (−0.36 – 1.00) 0.88 (0.43 – 1.34) 0.18 (−0.13 – 0.49)
IPDT 22.64 (5.9) 19.93 (5.4) 14.90 (6.7) 13.75 (8.4) 0.90 (0.21 – 1.58) 0.00 (−0.44 – 0.44)
PHQ-9
ICBT 13.03 (4.0) 10.63 (5.1) 6.17 (5.1) 5.75 (6.0) 0.11 (−0.63 – 0.85) 0.36 (−0.32 – 1.04) 1.02 (0.46 – 1.57) 0.19 (−0.12 – 0.50)
IPDT 14.14 (5.1) 11.93 (3.9) 6.70 (4.3) 7.92 (6.4) 1.08 (0.65 – 1.51) −0.21 (−0.56 – 0.15)
GAD-7
ICBT 8.60 (3.8) 7.33 (4.8) 5.09 (4.3) 3.71 (4.9) 0.14 (−0.61 – 0.88) 0.70 (0.00 – 1.39) 0.56 (0.15 – 0.97) 0.27 (0.01 – 0.53)
IPDT 7.57 (4.7) 8.71 (5.2) 5.70 (4.9) 7.08 (4.8) 0.63 (−0.05 – 1.31) −0.45 (−1.07 – 0.17)
BAI
ICBT 19.13 (10.0) 12.67 (8.6) 9.43 (8.1) 7.93 (9.9) 0.22 (−0.53 – 0.96) 0.38 (−0.30 – 1.06) 0.39 (0.04 – 0.75) 0.09 (−0.24 – 0.42)
IPDT 18.07 (9.7) 15.29 (9.9) 11.10 (6.6) 11.83 (11.0) 0.61 (−0.13 – 1.35) −0.23 (−0.74 – 0.28)
QOLI
ICBT −0.07 (1.1) 0.15 (1.5) 0.58 (1.6) 1.49 (1.7) 0.32 (−0.43 – 1.07) 0.67 (−0.02 – 1.36) 0.45 (0.06 – 0.83) 0.45 (0.13 – 0.78)
IPDT −0.19 (1.6) 0.33 (1.4) 0.09 (1.2) 0.46 (1.1) 0.22 (−0.14 – 0.57) −0.20 (−0.56 – 0.16)
Note: Pre ctrl = Time point before original trial started; Post ctrl/Pre tx = Time point at the end of the original trial period which also served as pre-treatment assessment in this study; Post tx = Time point at the end of
the treatment period; BDI-II = Beck Depression Inventory-II; MADRS-S =Montgomery Åsberg Depression Rating Scale - Self Rated; PHQ-9 = 9-item Patient Health Questionnaire Depression Scale; GAD-7 = 7-item Patient
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time, from pre-treatment to post-treatment, was found in
the IPDT group for the GAD-7 (F(1, 10.3) = 4.47, p = .06).
Random intercept models revealed a significant inter-
action effect of group and time on the QOLI, from pre-
treatment to follow-up, favoring ICBT. A post-hoc t-test
comparing the two groups at follow-up was marginally
significant, t(38) = 1.94, p = .06. No other interaction ef-
fects of group and time were found for secondary
measures.
From post-treatment to follow-up, there were significant
effects of time in the ICBT group for the GAD-7 (F(1,
24.1) = 4.89, p < .05) and the QOLI (F(1, 24.6) = 10.0,
p < .01). The corresponding within-group effect sizes were
d = 0.27 (95% CI: 0.01 – 0.53) for the GAD-7 and d = 0.45
(95% CI: 0.13 – 0.78) for the QOLI, indicating small but
significant improvements after treatment termination.
Recovery after treatment
There were no differences in recovery rates (post-treatment
BDI-II score of ≤ 10) between groups, neither at post-
treatment (IPDT: n= 5, 35.7%; ICBT: n= 9, 30.0%), χ2(N=
44, df= 1) = 0.14, p= 0.71, nor at follow-up (IPDT: n= 5,
35.7%; ICBT: n= 18, 60.0%), χ2(N= 44, df= 1) = 2.25, p=
0.13. However, the number of participants in the ICBTgroup
who recovered doubled from 30% at post-treatment to 60%
at follow-up. A separate analysis of the ICBT group revealed
a significant increase of recoverers from post-treatment to
follow-up (McNemar’s χ2(N= 30, df= 1) = 9.00, p < .01).
Preference and predicting treatment outcome
and adherence
The strength of preference was 2.90 (SD: 0.85) and 2.93
(SD: 1.07) in the ICBT group (N = 30) and the IPDT
group (N = 14), respectively. No significant difference in
this variable was observed (t(42) = 0.096, p = .92).
The prediction data regarding outcome for the two
groups on the BDI-II are presented in Table 3. For the en-
tire sample and for the IPDT group separately, strength of
preference was not correlated with treatment outcome,
neither at post-treatment nor at follow-up. However, in
the ICBT group, preference ratings predicted outcome at
the follow-up (r = −.42, p < .05).Table 3 Correlations (Pearson's r) between strength of
preference and outcome, adherence and completion of
the entire program
BDI-II post BDI-II follow-up Adherence Completion
ICBT -.13 -.42* .30 .16
IPDT .19 .42 .24 .50†
Total -.01 -.13 .28† .29†
Note: †p < .10 *p < .05. ICBT = Internet-based cognitive-behavioral therapy;
IPDT = Internet-based psychodynamic therapy; BDI-II = Beck
Depression Inventory-II.In the entire sample, there was a close to significant cor-
relation between strength of preference and adherence to
treatment (r = .28, p = .07). This correlation was not signifi-
cant in any subgroup analyses. For the IPDT group and for
the entire sample, there were trends towards significant cor-
relations between strength of preference and completion of
the treatment program (r = .50, p = .07 and r = .29, p = .06,
respectively).
Clinical global impression and adverse events
There were no differences between groups in degree of
improvement according to the CGI-I, χ2(N = 44, df = 1) =
0.42, p = 0.52. In the ICBT group and IPDT group respect-
ively, there were 16 and 6 participants (53.3% and 42.9%)
who were much or very much improved.
Two participants from the ICBT group were “minimally
worse” and “very much worse” as assessed by the CGI-I,
and were therefore classified as adverse events. Both these
participants stated change in medication as the reason for
feeling worse. An additional adverse event was noted as
one participant from the psychodynamic treatment group
was “much worse”. Reason for this was not clearly stated
by the participant.
Discussion
In this pilot study, we investigated differences between
psychodynamic and cognitive-behavioral psychotherapy
delivered via the Internet in a sample of participants
with major depression, where groups were formed based
on preference. We also investigated the predictive value
of the strength of preference. The main finding regard-
ing efficacy was that there were indications that those
choosing ICBT may have had some larger long-term
benefits in terms of quality of life. Another finding was
that completion of the entire program was higher among
participants who chose the psychodynamic treatment.
We also found indications that strength of preference
could predict adherence. Among participants choosing
psychodynamic treatment, completion of the program
was predicted by strength of preference. Moreover, par-
ticipants preferred ICBT over IPDT as significantly more
participants chose ICBT.
Despite a significantly larger rate of completion in the
psychodynamic treatment group, we found no indications
of differential efficacy during the treatment phase. How-
ever, indications of treatment differences were found at
the 7-month follow-up in favor of ICBT. This is somewhat
in line with results which show that participants having re-
ceived ICBT may benefit from it 3.5 years after completion
[33]. It is important to notice that all participants who did
not complete the entire treatment, did receive the
remaining modules after post-measurement. As data on
post-treatment use of treatment modules were not avail-
able, we could not perform any analyses to investigate if
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ued symptom reduction. While the two programs had a
similar amount of text, the ICBT treatment had homework
in the classical sense (completing exercises) and the IPDT
treatment had encouragements for working with the ma-
terial. The work that the ICBTgroup was doing was known
to the participants as “homework” while it in the IPDT
group was called “reflections”. The latter was more of writ-
ing about experiences than completing tasks. This could
have made a difference for how the participants worked
with the material and it could potentially be related to how
many participants completed the entire treatment. While
we in this study did not measure the amount of work done
by each participant, this could potentially also have been
affected by this difference in how the work was presented
to and handled by the participants.
This study also explored preferences, as all participants
had been allocated to their preferred choice of treatment
and had stated their strength of preference. The prefer-
ence literature suggest that an extra effect of having re-
ceived one’s preferred treatment should be expected. This
study can only speculate about this, as all preferences were
matched. However, the within-group effect size on the pri-
mary outcome measure in this study was around d = 1.0,
which seems quite low when compared to d = 2.18 from
the original trial [9]. Importantly, all participants from this
study had previously taken part of a support intervention
for 10 weeks, with substantial within-group effects. Still,
based on this comparison, data from this pilot study do
not seem to give any support for an extra effect of prefer-
ence matching. Importantly, the effect of preference
matching seems to be less important when comparing two
psychotherapies, than when comparing psychotherapy and
pharmacotherapy [12].
We also considered preference strength in this study.
Our indications that strength of preference could predict
adherence and completion of treatment are similar to
the results presented by Raue et al. [13]. In contrast to
the two previous studies [13,14] we found that strength
of preference could predict long-term treatment out-
come in the ICBT group. In summary, results regarding
preference strength are mixed. However, this study indi-
cates that strength of preference for treatment has some
predictive value and that further research is warranted.
There are limitations to this study that need to be
addressed. First, as one of the aims was to explore differ-
ences in efficacy between treatments, the study is under-
powered. If this question is to be further explored, a larger
sample needs to be used. Second, as all participants re-
ceived their preferred treatment, we could only explore the
effect of preference matching in an open study design. A
preferable design would be to randomize participants to ei-
ther a preferred or non preferred treatment arm [34].
Third, we did not explore therapist preferences, i.e.allegiance effects. We do not rule out that therapist prefer-
ences could have potentially made impact in this study and
acknowledge the effect of allegiance as an important area
for further research. Fourth, we did not measure factors
that could potentially explain differences in completion
rates, e.g. treatment satisfaction and perceived effort of tak-
ing part of treatment.
The findings from this pilot study suggest several re-
search issues. A larger, adequately powered, randomized
trial comparing the two treatments head-to-head could in-
vestigate differences in efficacy and the predictive value of
preference strength regarding treatment outcome and ad-
herence to treatment. If designed as a four-armed trial
(randomized to being given the choice or not, and if not,
randomized to treatment arm), as described by Howard
and Thornicroft [34], the trial could also investigate the
preference matching effect. This design would be a solu-
tion to all of the limitations mentioned above. Further-
more, as the effect of preference strength are largely
unexplored, one implication of this study is that we have
shown that strength of preference indeed may have some
predictive value and further inclusion of this in treatment
studies is warranted. Research on the effect of treatment
preference and strength of preference could potentially be
useful in dissemination of Internet-delivered psychological
treatments, where these factors could be taken into
consideration.
Conclusions
This exploratory study shows that there may be differ-
ences between psychodynamic and cognitive-behavioral
Internet-delivered psychotherapy. IPDT may lead to more
participants completing the treatment and ICBT may have
larger long-term benefits. More participants preferred
ICBT, but strength of preference was equally distributed
across the two groups. The study indicates that strength of
preference has a predictive value and should be included
in future studies investigating patients’ preferences.Competing interests
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